These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4281938)

  • 61. Fibrinogen and FDP-models of molecular pathology?
    Gaffney PJ
    Br J Haematol; 1973 Aug; 25(2):271-2. PubMed ID: 4269481
    [No Abstract]   [Full Text] [Related]  

  • 62. The destruction of factor VIII clotting activity by thrombin and plasmin.
    Denson KW; Redman CW
    Thromb Res; 1980 May 1-15; 18(3-4):547-9. PubMed ID: 6447928
    [No Abstract]   [Full Text] [Related]  

  • 63. Thrombin mimetic effects of estrogen: II. Gel filtration and centrifugal evidence for estrogen induced polymerization of fibrinogen derivatives.
    Pilgeram LO; vom dem Bussche G
    Thromb Res; 1975 Jan; 6(1):19-29. PubMed ID: 163506
    [No Abstract]   [Full Text] [Related]  

  • 64. Enhanced anticlotting activity of fragments D formed during plasmin hydrolysis of fibrinogen in the presence of calcium chloride.
    Belitser VA; Varetska TV; Tolstykh VM; Tsaryuk LA; Pozdnyakova TM
    Thromb Res; 1975 Nov; 7(5):797-806. PubMed ID: 128845
    [No Abstract]   [Full Text] [Related]  

  • 65. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates.
    Song YC; Sheng D; Taubenfeld SM; Matsueda GR
    Anal Biochem; 1994 Nov; 223(1):88-92. PubMed ID: 7695107
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Thrombocyte aggregation in depression and activation of the anticoagulation system of blood in animals].
    Pastorova VE
    Kardiologiia; 1976 Feb; 16(2):123-7. PubMed ID: 135113
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physiological inhibition of factor XIII.
    de Cataldo F; Baudo F
    Ann N Y Acad Sci; 1972 Dec; 202():341-3. PubMed ID: 4508932
    [No Abstract]   [Full Text] [Related]  

  • 68. Comparative hemostasis: studies on elasmobranchs.
    Lewis JH
    Comp Biochem Physiol A Comp Physiol; 1972 May; 42(1):233-40. PubMed ID: 4402712
    [No Abstract]   [Full Text] [Related]  

  • 69. Studies of the coagulation process in the crayfish, Orconectes virilis: attempts to identify a fibrinogen-like factor.
    Wood PJ; Karpawich PP
    Comp Biochem Physiol B; 1972 May; 42(1):41-8. PubMed ID: 5075770
    [No Abstract]   [Full Text] [Related]  

  • 70. Selective destruction of the platelet aggregation component in bovine factor VIII preparations by reduction.
    Brown JE; Baugh R; Hougie C
    Thromb Res; 1976 Jun; 8(6):777-83. PubMed ID: 960053
    [No Abstract]   [Full Text] [Related]  

  • 71. An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.
    Otis PT; Feinstein DI; Rapaport SI; Patch MJ
    Blood; 1974 Dec; 44(6):771-81. PubMed ID: 4214572
    [No Abstract]   [Full Text] [Related]  

  • 72. Proteolytic fragmentation of fibrinogen. I. Comparison of the fragmentation of human and bovine fibrinogen by trypsin or plasmin.
    Mihalyi E; Weinberg RM; Towne DW; Friedman ME
    Biochemistry; 1976 Nov; 15(24):5372-81. PubMed ID: 11813
    [No Abstract]   [Full Text] [Related]  

  • 73. Coagulation factors in human lymph and plasma.
    Stutman LJ; Dumont AE; Shinowara GY
    Am J Med Sci; 1965 Sep; 250(3):292-7. PubMed ID: 5829382
    [No Abstract]   [Full Text] [Related]  

  • 74. Hypo or hyper coagulability of blood with high levels of clotting factors.
    Nour-Eldin R; Lewis FJ
    Nature; 1966 Oct; 212(5060):417. PubMed ID: 5970163
    [No Abstract]   [Full Text] [Related]  

  • 75. Fibrinogen catabolism in burned patients.
    Alkjaersig N; Fletcher AP; Peden JC; Monafo WW
    J Trauma; 1980 Feb; 20(2):154-9. PubMed ID: 6965507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. THROMBOKINASE AS PRIME ACTIVATOR OF PROTHROMBIN: HISTORICAL PERSPECTIVES AND PRESENT STATUS.
    MILSTONE JH
    Fed Proc; 1964; 23():742-8. PubMed ID: 14195457
    [No Abstract]   [Full Text] [Related]  

  • 77. Increased prothrombin conversion: a new activity of lysed fibrinogen.
    Triantaphyllopoulos DC; Brunetti AJ; Triantaphyllopoulos E
    Br J Haematol; 1970 Feb; 18(2):127-34. PubMed ID: 5439521
    [No Abstract]   [Full Text] [Related]  

  • 78. Human platelet clumping by bovine fibrinogen during its degradation.
    De Gaetano G; Donati MB; Vermylen J
    Scand J Haematol Suppl; 1971; 13():281-3. PubMed ID: 4258203
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of hyperoxia on fibrinogen metabolism and clotting factors in rabbits.
    Senior RM; Sherman LA; Yin ET
    Am Rev Respir Dis; 1974 Jan; 109(1):156-61. PubMed ID: 4809156
    [No Abstract]   [Full Text] [Related]  

  • 80. Combinations of increased thrombin, plasmin and non-specific protease activity in patients with acute leukaemia.
    Galloway MJ; Mackie MJ; McVerry BA
    Haemostasis; 1983; 13(5):322-7. PubMed ID: 6228501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.